Espoo, Finland

Ilkka Pollari

This inventor holds 1 USPTO granted patent. Top assignee: Kemira Chemicals Oy. Active years: 2004.


Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ilkka Pollari: Innovator in Antimicrobial Solutions

Introduction

Ilkka Pollari is a notable inventor based in Espoo, Finland. He has made significant contributions to the field of antimicrobial products, particularly through his innovative approach to preserving organic materials. His work is characterized by a focus on practical applications that address real-world challenges.

Latest Patents

Pollari holds a patent for a solid formic acid product. This invention relates to a solid antimicrobial product suitable for the preservation of organic material and for combating detrimental microorganisms, as well as for pH control. The product contains concentrated formic acid, which is partly neutralized with gaseous ammonia, and has a water content of less than 2% by weight. Additionally, the invention includes a method for preparing this product, showcasing Pollari's commitment to advancing antimicrobial technology.

Career Highlights

Ilkka Pollari is associated with Kemira Chemicals Oy, a company known for its focus on sustainable solutions in the chemical industry. His role at Kemira has allowed him to leverage his expertise in developing innovative products that meet the needs of various industries.

Collaborations

Pollari has collaborated with notable colleagues, including Eero Aitta and Jouko Arvola. These partnerships have contributed to the successful development and implementation of his inventions, fostering a collaborative environment that encourages innovation.

Conclusion

Ilkka Pollari's contributions to the field of antimicrobial solutions highlight his innovative spirit and dedication to addressing pressing challenges in material preservation. His work continues to influence the industry and pave the way for future advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…